REXPRIDE GMP2
Glimepiride, Pioglitazone & Metformin HCl (SR) Tablets
Anti-diabetic
Schedule H Rx
Genuine RexCure Batch PackagingImage 1 of 2
VOGLIREX-VM 2.2
Glimepiride, Metformin HCl (SR) & Voglibose Tablets
Triple-combination anti-diabetic tablet for synchronized fasting and post-prandial glucose control in Type 2 Diabetes.
Strength
2 mg + 500 mg + 0.2 mg
Commercial Pack
Strip of 10 Tablets
Indicative MRP
Rs. 135.00
Drug Class
Schedule H Rx
Active Chemical Composition
Each film-coated tablet contains:
- Glimepiride 2 mg
- Metformin Hydrochloride (SR) 500 mg
- Voglibose 0.2 mg
- Excipients q.s.
Primary Clinical Indications
1
Type 2 Diabetes Mellitus
2
Post-prandial glycemic excursions
3
Long-term HbA1c management
Therapeutic Pharmacology & Overview
VOGLIREX-VM 2.2 combines Glimepiride (secretagogue), Metformin HCl Sustained Release (insulin sensitizer), and Voglibose (alpha-glucosidase inhibitor) to curb glycemic spikes and support HbA1c reduction.
Key Formulation Advantages
Synchronized control of fasting and post-meal glucose spikes
Voglibose delays carbohydrate digestion without insulin stimulation
Metformin SR provides steady 24-hour hepatic glucose modulation
Single-tablet triple combination significantly improves patient adherence
Dosage & Administration
Standard Adult / Pediatric Regimen:
1 tablet once or twice daily with meals, or strictly as directed by physician.
Disclaimer: Dosage must be strictly adjusted by treating physicians based on clinical severity, renal clearance, and body weight.
Packaging & Storage Details
Commercial Presentation:
10 × 10 Alu-Alu Blister Strip in mono-carton
Storage Monograph:
Store protected from moisture and direct sunlight below 25°C
Market Authorization Holder:
RexCure Pharmaceuticals Pvt. Ltd.
Hyderabad, Telangana
Clinical Inquiry / Sample Request
Healthcare practitioners and hospital pharmacies may request detailed product dossiers, bio-equivalence data, or clinic samples.
Contact Medical DeskDrug Law Compliance
Marketed under Drugs and Cosmetics Act, 1940 and Rules thereunder. Distributed exclusively through licensed pharmaceutical wholesalers and pharmacies.Segment Portfolio
View Area (All) →Related Formulations in Diabetology & Metabolic Care